Biocept Inc. (BIOCQ) — Working Capital to Net Assets Ratio
Biocept Inc. (BIOCQ) has a Working Capital to Net Assets ratio of 1364.8% as of June 2023. Working capital of $3.96 Million (current assets of $8.86 Million minus current liabilities of $4.90 Million) is measured against net assets of $290.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Biocept Inc. to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Biocept Inc. Working Capital to Net Assets (2019–2022)
This chart shows how Biocept Inc.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the ratio stands at 1364.8%, reflecting working capital of $3.96 Million against net assets of $290.00K USD. See defensive interval ratio of Biocept Inc. to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Biocept Inc. (2019–2022)
The table below presents the year-by-year Working Capital to Net Assets ratio for Biocept Inc. from 2019 to 2022, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Biocept Inc. (BIOCQ) total market value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 122.3% | $10.84 Million | $8.86 Million | $16.34 Million | $5.51 Million | ▲ +31.8 pp |
| 2021 | 90.5% | $33.92 Million | $37.48 Million | $45.69 Million | $11.77 Million | ▲ +5.7 pp |
| 2020 | 84.8% | $20.10 Million | $23.69 Million | $32.59 Million | $12.49 Million | ▲ +10.4 pp |
| 2019 | 74.4% | $8.33 Million | $11.20 Million | $13.89 Million | $5.56 Million | — |